Medacta Group (Switzerland) Performance
| MOVE Stock | 134.80 1.20 0.90% |
On a scale of 0 to 100, Medacta Group holds a performance score of 14. The company secures a Beta (Market Risk) of 0.14, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medacta Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medacta Group is expected to be smaller as well. Please check Medacta Group's coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to make a quick decision on whether Medacta Group's current price movements will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Medacta Group SA are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Medacta Group showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 48.1 M | |
| Total Cashflows From Investing Activities | -52 M |
Medacta |
Medacta Group Relative Risk vs. Return Landscape
If you would invest 10,900 in Medacta Group SA on December 5, 2024 and sell it today you would earn a total of 2,580 from holding Medacta Group SA or generate 23.67% return on investment over 90 days. Medacta Group SA is generating 0.3868% of daily returns and assumes 2.0437% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than Medacta, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Medacta Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medacta Group's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medacta Group SA, and traders can use it to determine the average amount a Medacta Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1892
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MOVE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.04 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Medacta Group is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medacta Group by adding it to a well-diversified portfolio.
Medacta Group Fundamentals Growth
Medacta Stock prices reflect investors' perceptions of the future prospects and financial health of Medacta Group, and Medacta Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medacta Stock performance.
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0752 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 1.98 B | |||
| Shares Outstanding | 19.98 M | |||
| Price To Book | 7.98 X | |||
| Price To Sales | 4.85 X | |||
| Revenue | 363.13 M | |||
| EBITDA | 99.33 M | |||
| Total Debt | 63.17 M | |||
| Book Value Per Share | 12.62 X | |||
| Cash Flow From Operations | 54.06 M | |||
| Earnings Per Share | 2.38 X | |||
| Total Asset | 489.27 M | |||
About Medacta Group Performance
Evaluating Medacta Group's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Medacta Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medacta Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Medacta Group SA performance evaluation
Checking the ongoing alerts about Medacta Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medacta Group SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 70.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Medacta Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medacta Group's stock is overvalued or undervalued compared to its peers.
- Examining Medacta Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medacta Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medacta Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medacta Group's stock. These opinions can provide insight into Medacta Group's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Medacta Stock Analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.